Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2012

Open Access 01-12-2012 | Research article

Individual participant data meta-analysis of prognostic factor studies: state of the art?

Authors: Ghada Abo-Zaid, Willi Sauerbrei, Richard D Riley

Published in: BMC Medical Research Methodology | Issue 1/2012

Login to get access

Abstract

Background

Prognostic factors are associated with the risk of a subsequent outcome in people with a given disease or health condition. Meta-analysis using individual participant data (IPD), where the raw data are synthesised from multiple studies, has been championed as the gold-standard for synthesising prognostic factor studies. We assessed the feasibility and conduct of this approach.

Methods

A systematic review to identify published IPD meta-analyses of prognostic factors studies, followed by detailed assessment of a random sample of 20 articles published from 2006. Six of these 20 articles were from the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in traumatic brain injury) collaboration, for which additional information was also used from simultaneously published companion papers.

Results

Forty-eight published IPD meta-analyses of prognostic factors were identified up to March 2009. Only three were published before 2000 but thereafter a median of four articles exist per year, with traumatic brain injury the most active research field. Availability of IPD offered many advantages, such as checking modelling assumptions; analysing variables on their continuous scale with the possibility of assessing for non-linear relationships; and obtaining results adjusted for other variables. However, researchers also faced many challenges, such as large cost and time required to obtain and clean IPD; unavailable IPD for some studies; different sets of prognostic factors in each study; and variability in study methods of measurement. The IMPACT initiative is a leading example, and had generally strong design, methodological and statistical standards. Elsewhere, standards are not always as high and improvements in the conduct of IPD meta-analyses of prognostic factor studies are often needed; in particular, continuous variables are often categorised without reason; publication bias and availability bias are rarely examined; and important methodological details and summary results are often inadequately reported.

Conclusions

IPD meta-analyses of prognostic factors are achievable and offer many advantages, as displayed most expertly by the IMPACT initiative. However such projects face numerous logistical and methodological obstacles, and their conduct and reporting can often be substantially improved.
Appendix
Available only for authorised users
Literature
1.
go back to reference Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JDF, et al: Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008, 5 (8): 1251-1261.CrossRef Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JDF, et al: Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008, 5 (8): 1251-1261.CrossRef
2.
go back to reference Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Ferno M, Eppenberger-Castori S, et al: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst. 2002, 94 (2): 116-128. 10.1093/jnci/94.2.116.CrossRefPubMed Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Ferno M, Eppenberger-Castori S, et al: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst. 2002, 94 (2): 116-128. 10.1093/jnci/94.2.116.CrossRefPubMed
3.
go back to reference Sauerbrei W: Covariates. Wiley Encyclopedia of Clinical Trials. 2007, 1-13. Sauerbrei W: Covariates. Wiley Encyclopedia of Clinical Trials. 2007, 1-13.
4.
go back to reference Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW: Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007, 24 (2): 232-238. 10.1089/neu.2006.0024.CrossRefPubMed Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW: Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007, 24 (2): 232-238. 10.1089/neu.2006.0024.CrossRefPubMed
5.
go back to reference Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006, 25 (1): 127-141. 10.1002/sim.2331.CrossRefPubMed Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006, 25 (1): 127-141. 10.1002/sim.2331.CrossRefPubMed
6.
go back to reference Royston P, Moons KGM, Altman DG, Vergouwe Y: Prognosis and prognostic research: developing a prognostic model. Br Med J. 2009, 338 (b604): 1373-1377. Royston P, Moons KGM, Altman DG, Vergouwe Y: Prognosis and prognostic research: developing a prognostic model. Br Med J. 2009, 338 (b604): 1373-1377.
7.
go back to reference Cianfrocca M, Goldstein LJ: Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004, 9 (6): 606-616. 10.1634/theoncologist.9-6-606.CrossRefPubMed Cianfrocca M, Goldstein LJ: Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004, 9 (6): 606-616. 10.1634/theoncologist.9-6-606.CrossRefPubMed
8.
go back to reference Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D, Burchill SA: Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer. 2003, 88 (8): 1191-1198. 10.1038/sj.bjc.6600886.CrossRefPubMedPubMedCentral Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D, Burchill SA: Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer. 2003, 88 (8): 1191-1198. 10.1038/sj.bjc.6600886.CrossRefPubMedPubMedCentral
9.
go back to reference Holländer N, Sauerbrei W: On statistical approaches for the multivariable analysis of prognostic factor studies. Advances in statistical methods for the health sciences. Edited by: Auget J-L, Balakrishnan N, Mesbah M, Molenberghs G. 2006, Birkhäuser, Boston, 19-38. Holländer N, Sauerbrei W: On statistical approaches for the multivariable analysis of prognostic factor studies. Advances in statistical methods for the health sciences. Edited by: Auget J-L, Balakrishnan N, Mesbah M, Molenberghs G. 2006, Birkhäuser, Boston, 19-38.
10.
go back to reference Kyzas PA, Loizou KT, Ioannidis JP: Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005, 97 (14): 1043-1055. 10.1093/jnci/dji184.CrossRefPubMed Kyzas PA, Loizou KT, Ioannidis JP: Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005, 97 (14): 1043-1055. 10.1093/jnci/dji184.CrossRefPubMed
11.
go back to reference Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J: Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. Health Technol Assess. 2009, 13 (5): 1-219. iii, xi-xiiiCrossRef Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J: Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review. Health Technol Assess. 2009, 13 (5): 1-219. iii, xi-xiiiCrossRef
12.
go back to reference Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet. 1993, 341 (8842): 418-422. 10.1016/0140-6736(93)93004-K.CrossRefPubMed Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet. 1993, 341 (8842): 418-422. 10.1016/0140-6736(93)93004-K.CrossRefPubMed
13.
go back to reference Riley RD, Sauerbrei W, Altman DG: Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer. 2009, 100 (8): 1219-1229. 10.1038/sj.bjc.6604999.CrossRefPubMedPubMedCentral Riley RD, Sauerbrei W, Altman DG: Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer. 2009, 100 (8): 1219-1229. 10.1038/sj.bjc.6604999.CrossRefPubMedPubMedCentral
14.
go back to reference Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG: Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol. 2007, 8 (6): 488-499. 10.1016/S1470-2045(07)70145-6.CrossRefPubMed Trivella M, Pezzella F, Pastorino U, Harris AL, Altman DG: Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol. 2007, 8 (6): 488-499. 10.1016/S1470-2045(07)70145-6.CrossRefPubMed
15.
go back to reference Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C: Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999, 28 (1): 1-9. 10.1093/ije/28.1.1.CrossRefPubMed Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C: Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999, 28 (1): 1-9. 10.1093/ije/28.1.1.CrossRefPubMed
16.
go back to reference Riley RD, Lambert PC, Abo-Zaid G: Meta-analysis of individual participant data: conduct, rationale and reporting. BMJ. 2010, 340: c221-10.1136/bmj.c221.CrossRefPubMed Riley RD, Lambert PC, Abo-Zaid G: Meta-analysis of individual participant data: conduct, rationale and reporting. BMJ. 2010, 340: c221-10.1136/bmj.c221.CrossRefPubMed
17.
go back to reference Altman DG, Trivella M, Pezzella F, Harris AL, Pastorino U: Systematic review of multiple studies of prognosis: the feasibility of obtaining individual patient data. I. Advances in statistical methods for the health sciences. Edited by: Auget J-L, Balakrishnan N, Mesbah M, Molenberghs G. 2006, Birkhäuser, Boston, 3-18. Altman DG, Trivella M, Pezzella F, Harris AL, Pastorino U: Systematic review of multiple studies of prognosis: the feasibility of obtaining individual patient data. I. Advances in statistical methods for the health sciences. Edited by: Auget J-L, Balakrishnan N, Mesbah M, Molenberghs G. 2006, Birkhäuser, Boston, 3-18.
18.
go back to reference Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP: The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2002, 87 (7): 694-701. 10.1038/sj.bjc.6600551.CrossRefPubMedPubMedCentral Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP: The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2002, 87 (7): 694-701. 10.1038/sj.bjc.6600551.CrossRefPubMedPubMedCentral
19.
go back to reference Riley RD: Commentary: Like it and lump it? Meta-analysis using individual participant data. Int J Epidemiol. 2010, 39 (5): 1359-1361. 10.1093/ije/dyq129.CrossRefPubMed Riley RD: Commentary: Like it and lump it? Meta-analysis using individual participant data. Int J Epidemiol. 2010, 39 (5): 1359-1361. 10.1093/ije/dyq129.CrossRefPubMed
20.
go back to reference Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR: Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol. 2002, 156 (3): 204-210. 10.1093/aje/kwf031.CrossRefPubMed Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR: Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol. 2002, 156 (3): 204-210. 10.1093/aje/kwf031.CrossRefPubMed
21.
go back to reference Moons KG, Altman DG, Vergouwe Y, Royston P: Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009, 338: b606-10.1136/bmj.b606.CrossRefPubMed Moons KG, Altman DG, Vergouwe Y, Royston P: Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009, 338: b606-10.1136/bmj.b606.CrossRefPubMed
22.
go back to reference Hemingway H, Riley RD, Altman DG: Ten steps towards improving prognosis research. BMJ. 2009, 339: b4184-10.1136/bmj.b4184.CrossRefPubMed Hemingway H, Riley RD, Altman DG: Ten steps towards improving prognosis research. BMJ. 2009, 339: b4184-10.1136/bmj.b4184.CrossRefPubMed
23.
go back to reference Riley RD, Simmonds MC, Look MP: Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol. 2007, 60 (5): 431-439.CrossRefPubMed Riley RD, Simmonds MC, Look MP: Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J Clin Epidemiol. 2007, 60 (5): 431-439.CrossRefPubMed
24.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15)): 2008-2012.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15)): 2008-2012.CrossRefPubMed
25.
go back to reference Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999, 354 (9193)): 1896-1900.CrossRefPubMed Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999, 354 (9193)): 1896-1900.CrossRefPubMed
26.
go back to reference Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI: IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007, 24 (2): 239-250. 10.1089/neu.2006.0036.CrossRefPubMed Marmarou A, Lu J, Butcher I, McHugh GS, Mushkudiani NA, Murray GD, Steyerberg EW, Maas AI: IMPACT database of traumatic brain injury: design and description. J Neurotrauma. 2007, 24 (2): 239-250. 10.1089/neu.2006.0036.CrossRefPubMed
27.
go back to reference MeRGE collaborators: Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis. Circulation. 2008, 117 (20)): 2591-2598. MeRGE collaborators: Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis. Circulation. 2008, 117 (20)): 2591-2598.
28.
go back to reference Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AIR, Marmarou A, Steyerberg EW: Multivariable prognostic analysis in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): p329-p337. 10.1089/neu.2006.0035.CrossRef Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, Maas AIR, Marmarou A, Steyerberg EW: Multivariable prognostic analysis in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): p329-p337. 10.1089/neu.2006.0035.CrossRef
29.
go back to reference Butcher I, Maas AIR, Lu J, Marmarou A, Murray GD, Mushkudiani NA, McHugh GS, Steyerberg EW: Prognostic value of admission blood pressure in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 294-302. 10.1089/neu.2006.0032.CrossRefPubMed Butcher I, Maas AIR, Lu J, Marmarou A, Murray GD, Mushkudiani NA, McHugh GS, Steyerberg EW: Prognostic value of admission blood pressure in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 294-302. 10.1089/neu.2006.0032.CrossRefPubMed
30.
go back to reference Van Beek JGM, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, Lu J, Marmarou A, Murray GD, Maas AIR: Prognostic value of admission laboratory parameters in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 315-328. 10.1089/neu.2006.0034.CrossRefPubMed Van Beek JGM, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, Lu J, Marmarou A, Murray GD, Maas AIR: Prognostic value of admission laboratory parameters in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 315-328. 10.1089/neu.2006.0034.CrossRefPubMed
31.
go back to reference Maas AIR, Steyerberg EW, Butcher I, Dammers R, Lu J, Marmarou A, Mushkudiani NA, McHugh GS, Murray GD: Prognostic value of computerized tomography scan characteristics in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 303-314. 10.1089/neu.2006.0033.CrossRefPubMed Maas AIR, Steyerberg EW, Butcher I, Dammers R, Lu J, Marmarou A, Mushkudiani NA, McHugh GS, Murray GD: Prognostic value of computerized tomography scan characteristics in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 303-314. 10.1089/neu.2006.0033.CrossRefPubMed
32.
go back to reference Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, Marmarou A, Slieker F, McHugh GS, Murray GD, Maas AIR: Prognostic value of demographic characteristics in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 259-269. 10.1089/neu.2006.0028.CrossRefPubMed Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, Marmarou A, Slieker F, McHugh GS, Murray GD, Maas AIR: Prognostic value of demographic characteristics in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 259-269. 10.1089/neu.2006.0028.CrossRefPubMed
33.
go back to reference McHugh GS, Engel DC, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Hernandez AV, Marmarou A, Maas AIR, Murray GD: Prognostic value of secondary insults in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 287-293. 10.1089/neu.2006.0031.CrossRefPubMed McHugh GS, Engel DC, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Hernandez AV, Marmarou A, Maas AIR, Murray GD: Prognostic value of secondary insults in traumatic brain injury: Results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 287-293. 10.1089/neu.2006.0031.CrossRefPubMed
34.
go back to reference Butcher I, McHugh GS, Lu J, Steyerberg EW, Hernandez AV, Mushkudiani N, Maas AI, Marmarou A, Murray GD: Prognostic value of cause of injury in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 281-286. 10.1089/neu.2006.0030.CrossRefPubMed Butcher I, McHugh GS, Lu J, Steyerberg EW, Hernandez AV, Mushkudiani N, Maas AI, Marmarou A, Murray GD: Prognostic value of cause of injury in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007, 24 (2): 281-286. 10.1089/neu.2006.0030.CrossRefPubMed
35.
go back to reference Marmarou A, Lu J, Butcher I, McHugh GS, Murray GD, Steyerberg EW, Mushkudiani NA, Choi S, Maas AI: Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis. J Neurotrauma. 2007, 24 (2): 270-280. 10.1089/neu.2006.0029.CrossRefPubMed Marmarou A, Lu J, Butcher I, McHugh GS, Murray GD, Steyerberg EW, Mushkudiani NA, Choi S, Maas AI: Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis. J Neurotrauma. 2007, 24 (2): 270-280. 10.1089/neu.2006.0029.CrossRefPubMed
36.
go back to reference Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Kober L, Connolly SJ, Gallagher MM, Camm AJ: Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator - A prognostic indicator. Int J Cardiol. 2008, 126 (1): 101-107. 10.1016/j.ijcard.2007.03.122.CrossRefPubMed Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Kober L, Connolly SJ, Gallagher MM, Camm AJ: Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator - A prognostic indicator. Int J Cardiol. 2008, 126 (1): 101-107. 10.1016/j.ijcard.2007.03.122.CrossRefPubMed
37.
go back to reference Thakkinstian A, Dmitrienko S, Gerbase-DeLima M, McDaniel DO, Inigo P, Chow KM, McEvoy M, Ingsathit A, Trevillian P, Barber WH, et al: Association between cytokine gene polymorphisms and outcomes in renal transplantation: A meta-analysis of individual patient data. Nephrol Dial Transplant. 2008, 23 (9): 3017-3023. 10.1093/ndt/gfn185.CrossRefPubMed Thakkinstian A, Dmitrienko S, Gerbase-DeLima M, McDaniel DO, Inigo P, Chow KM, McEvoy M, Ingsathit A, Trevillian P, Barber WH, et al: Association between cytokine gene polymorphisms and outcomes in renal transplantation: A meta-analysis of individual patient data. Nephrol Dial Transplant. 2008, 23 (9): 3017-3023. 10.1093/ndt/gfn185.CrossRefPubMed
38.
go back to reference Koopman L, Hoes AW, Glasziou PP, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, Le SN, Rovers MM: Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: A meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg. 2008, 134 (2): 128-132. 10.1001/archoto.2007.3.CrossRefPubMed Koopman L, Hoes AW, Glasziou PP, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, Le SN, Rovers MM: Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: A meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg. 2008, 134 (2): 128-132. 10.1001/archoto.2007.3.CrossRefPubMed
39.
go back to reference Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, et al: Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008, 23 (5): 690-699. 10.1002/mds.21894.CrossRefPubMed Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, et al: Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008, 23 (5): 690-699. 10.1002/mds.21894.CrossRefPubMed
40.
go back to reference MeRGE collaborators: Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis. Eur J Heart Fail. 2008, 10 (8)): 786-792. MeRGE collaborators: Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis. Eur J Heart Fail. 2008, 10 (8)): 786-792.
41.
go back to reference Sylaja PN, Dong W, Grotta JC, Miller MK, Tomita K, Hamilton S, Semba C, Hill MD: Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Neurocrit Care. 2007, 6 (3): 181-185. 10.1007/s12028-007-0018-8.CrossRefPubMed Sylaja PN, Dong W, Grotta JC, Miller MK, Tomita K, Hamilton S, Semba C, Hill MD: Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Neurocrit Care. 2007, 6 (3): 181-185. 10.1007/s12028-007-0018-8.CrossRefPubMed
42.
go back to reference Schaich M, Schlenk RF, Al-Ali HK, Dohner H, Ganser A, Heil G, Illmer T, Krahl R, Krauter J, Sauerland C, et al: Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: Individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica. 2007, 92 (6): 763-770. 10.3324/haematol.11100.CrossRefPubMed Schaich M, Schlenk RF, Al-Ali HK, Dohner H, Ganser A, Heil G, Illmer T, Krahl R, Krauter J, Sauerland C, et al: Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: Individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica. 2007, 92 (6): 763-770. 10.3324/haematol.11100.CrossRefPubMed
43.
go back to reference Rovers MM, Glasziou P, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, Little P, Le SN, Hoes AW: Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: A meta-analysis of individual patient data. Pediatrics. 2007, 119 (3): 579-585. 10.1542/peds.2006-2092.CrossRefPubMed Rovers MM, Glasziou P, Appelman CL, Burke P, McCormick DP, Damoiseaux RA, Little P, Le SN, Hoes AW: Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: A meta-analysis of individual patient data. Pediatrics. 2007, 119 (3): 579-585. 10.1542/peds.2006-2092.CrossRefPubMed
44.
go back to reference Noordzij JP, Lee SL, Bernet VJ, Payne RJ, Cohen SM, McLeod IK, Hier MP, Black MJ, Kerr PD, Richards ML, et al: Early Prediction of Hypocalcemia after Thyroidectomy using Parathyroid Hormone: An Analysis of Pooled Individual Patient Data from Nine Observational Studies. J Am Coll Surg. 2007, 205 (6): 748-754. 10.1016/j.jamcollsurg.2007.06.298.CrossRefPubMed Noordzij JP, Lee SL, Bernet VJ, Payne RJ, Cohen SM, McLeod IK, Hier MP, Black MJ, Kerr PD, Richards ML, et al: Early Prediction of Hypocalcemia after Thyroidectomy using Parathyroid Hormone: An Analysis of Pooled Individual Patient Data from Nine Observational Studies. J Am Coll Surg. 2007, 205 (6): 748-754. 10.1016/j.jamcollsurg.2007.06.298.CrossRefPubMed
45.
go back to reference Lanterna LA, Ruigrok Y, Alexander S, Tang J, Biroli F, Dunn LT, Poon WS: Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia. Neurology. 2007, 69 (8): 766-775. 10.1212/01.wnl.0000267640.03300.6b.CrossRefPubMed Lanterna LA, Ruigrok Y, Alexander S, Tang J, Biroli F, Dunn LT, Poon WS: Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia. Neurology. 2007, 69 (8): 766-775. 10.1212/01.wnl.0000267640.03300.6b.CrossRefPubMed
46.
go back to reference Downing M, Lau F, Lesperance M, Karlson N, Shaw J, Kuziemsky C, Bernard S, Hanson L, Olajide L, Head B, et al: Meta-analysis of survival prediction with Palliative Performance Scale. J Palliat Care. 2007, 23 (4): 245-252.PubMed Downing M, Lau F, Lesperance M, Karlson N, Shaw J, Kuziemsky C, Bernard S, Hanson L, Olajide L, Head B, et al: Meta-analysis of survival prediction with Palliative Performance Scale. J Palliat Care. 2007, 23 (4): 245-252.PubMed
47.
go back to reference Warkentin TE, Sheppard J-A, Sigouin CS, Kohlmann T, Eichler P, Greinacher A: Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006, 108 (9): 2937-2941. 10.1182/blood-2005-11-012450.CrossRefPubMed Warkentin TE, Sheppard J-A, Sigouin CS, Kohlmann T, Eichler P, Greinacher A: Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006, 108 (9): 2937-2941. 10.1182/blood-2005-11-012450.CrossRefPubMed
48.
go back to reference McHugh GS, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Marmarou A, Maas AI, Murray GD: Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury. J Neurotrauma. 2007, 24 (2): 251-258. 10.1089/neu.2006.0026.CrossRefPubMed McHugh GS, Butcher I, Steyerberg EW, Lu J, Mushkudiani N, Marmarou A, Maas AI, Murray GD: Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury. J Neurotrauma. 2007, 24 (2): 251-258. 10.1089/neu.2006.0026.CrossRefPubMed
49.
go back to reference Hayden JA, Cote P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006, 144 (6): 427-437.CrossRefPubMed Hayden JA, Cote P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006, 144 (6): 427-437.CrossRefPubMed
50.
go back to reference Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins JPT, Green S. 2008, John Wiley & Sons, Chichester Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins JPT, Green S. 2008, John Wiley & Sons, Chichester
52.
go back to reference Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F: Methods for Meta-analysis in Medical Research. 2000, John Wiley, London Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F: Methods for Meta-analysis in Medical Research. 2000, John Wiley, London
53.
go back to reference Thompson SG, Kaptoge S, White I, Wood A, Perry P, Danesh J: Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol. 2010, 39 (5): 1345-1359. 10.1093/ije/dyq063.CrossRefPubMedPubMedCentral Thompson SG, Kaptoge S, White I, Wood A, Perry P, Danesh J: Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol. 2010, 39 (5): 1345-1359. 10.1093/ije/dyq063.CrossRefPubMedPubMedCentral
54.
55.
go back to reference DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed
56.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.CrossRefPubMedPubMedCentral Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.CrossRefPubMedPubMedCentral
57.
go back to reference Riley RD, Steyerberg EW: Meta-analysis of a binary outcome using individual participant data and aggregate data. Journal of Research Synthesis Methods. 2010, 1: 2-9. 10.1002/jrsm.4.CrossRefPubMed Riley RD, Steyerberg EW: Meta-analysis of a binary outcome using individual participant data and aggregate data. Journal of Research Synthesis Methods. 2010, 1: 2-9. 10.1002/jrsm.4.CrossRefPubMed
58.
go back to reference Broeze KA, Opmeer BC, Bachmann LM, Broekmans FJ, Bossuyt PM, Coppus SF, Johnson NP, Khan KS, ter Riet G, van der Veen F, et al: Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine. BMC Med Res Methodol. 2009, 9: 22-10.1186/1471-2288-9-22.CrossRefPubMedPubMedCentral Broeze KA, Opmeer BC, Bachmann LM, Broekmans FJ, Bossuyt PM, Coppus SF, Johnson NP, Khan KS, ter Riet G, van der Veen F, et al: Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine. BMC Med Res Methodol. 2009, 9: 22-10.1186/1471-2288-9-22.CrossRefPubMedPubMedCentral
59.
go back to reference Sauerbrei W: Prognostic Factors - Confusion caused by bad quality of design, analysis and reporting of many studies. Current Research in Head and Neck CancerAdvances in Oto-Rhino-Laryngology. Volume 62. Edited by: Bier H. 2005, Karger, Basel, 184-200. Sauerbrei W: Prognostic Factors - Confusion caused by bad quality of design, analysis and reporting of many studies. Current Research in Head and Neck CancerAdvances in Oto-Rhino-Laryngology. Volume 62. Edited by: Bier H. 2005, Karger, Basel, 184-200.
60.
go back to reference Sauerbrei W, Blettner M, Royston P: On alcohol consumption and all-cause mortality. J Clin Epidemiol. 2001, 54: 537-538. 10.1016/S0895-4356(00)00246-8.CrossRef Sauerbrei W, Blettner M, Royston P: On alcohol consumption and all-cause mortality. J Clin Epidemiol. 2001, 54: 537-538. 10.1016/S0895-4356(00)00246-8.CrossRef
61.
go back to reference Sauerbrei W, Holländer N, Riley RD, Altman DG: Evidence-based assessment and application of prognostic markers: the long way from single studies to meta-analysis. Communications in Statistics. 2006, 35: 1333-1342. 10.1080/03610920600629666.CrossRef Sauerbrei W, Holländer N, Riley RD, Altman DG: Evidence-based assessment and application of prognostic markers: the long way from single studies to meta-analysis. Communications in Statistics. 2006, 35: 1333-1342. 10.1080/03610920600629666.CrossRef
62.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group): Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535-10.1136/bmj.b2535.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group): Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535-10.1136/bmj.b2535.CrossRefPubMedPubMedCentral
63.
go back to reference McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Diagnostics ftSSotN-EWoC: REporting recommendations for tumor MARKer prognostic studies (REMARK). J Natl Cancer Inst. 2005, 97 (16)): 1180-1184.CrossRefPubMed McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Diagnostics ftSSotN-EWoC: REporting recommendations for tumor MARKer prognostic studies (REMARK). J Natl Cancer Inst. 2005, 97 (16)): 1180-1184.CrossRefPubMed
64.
go back to reference Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG: A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med. 2000, 19 (24): 3417-3432. 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L.CrossRefPubMed Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG: A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med. 2000, 19 (24): 3417-3432. 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L.CrossRefPubMed
65.
go back to reference Higgins JP, Whitehead A, Turner RM, Omar RZ, Thompson SG: Meta-analysis of continuous outcome data from individual patients. Stat Med. 2001, 20 (15): 2219-2241. 10.1002/sim.918.CrossRefPubMed Higgins JP, Whitehead A, Turner RM, Omar RZ, Thompson SG: Meta-analysis of continuous outcome data from individual patients. Stat Med. 2001, 20 (15): 2219-2241. 10.1002/sim.918.CrossRefPubMed
66.
go back to reference Tudur-Smith C, Williamson PR, Marson AG: Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med. 2005, 24 (9): 1307-1319. 10.1002/sim.2050.CrossRef Tudur-Smith C, Williamson PR, Marson AG: Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med. 2005, 24 (9): 1307-1319. 10.1002/sim.2050.CrossRef
67.
go back to reference Steyerberg EW: Clinical prediction models: a practical approach to development, validation, and updating. 2009, Springer, New YorkCrossRef Steyerberg EW: Clinical prediction models: a practical approach to development, validation, and updating. 2009, Springer, New YorkCrossRef
68.
go back to reference Riley RD, Higgins JP, Deeks JJ: Interpretation of random effects meta-analyses. BMJ. 2011, 342: d549-10.1136/bmj.d549.CrossRefPubMed Riley RD, Higgins JP, Deeks JJ: Interpretation of random effects meta-analyses. BMJ. 2011, 342: d549-10.1136/bmj.d549.CrossRefPubMed
69.
go back to reference Higgins JP, Thompson SG, Spiegelhalter DJ: A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society, Series A. 2009, 172: 137-159.CrossRef Higgins JP, Thompson SG, Spiegelhalter DJ: A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society, Series A. 2009, 172: 137-159.CrossRef
70.
go back to reference Ahmed I, Sutton AJ, Riley RD: Assessment of publication bias, selection bias and unavailable data in meta-analyses using individual participant data: a database survey. BMJ. 2012, 344: d7762-10.1136/bmj.d7762.CrossRefPubMed Ahmed I, Sutton AJ, Riley RD: Assessment of publication bias, selection bias and unavailable data in meta-analyses using individual participant data: a database survey. BMJ. 2012, 344: d7762-10.1136/bmj.d7762.CrossRefPubMed
71.
go back to reference Kyzas PA, Denaxa-Kyza D, Ioannidis JP: Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer. 2007, 43 (17): 2559-2579. 10.1016/j.ejca.2007.08.030.CrossRefPubMed Kyzas PA, Denaxa-Kyza D, Ioannidis JP: Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer. 2007, 43 (17): 2559-2579. 10.1016/j.ejca.2007.08.030.CrossRefPubMed
72.
go back to reference Sterne JAC, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, A.J. S J.P.A. I, et al: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 342: d4002-CrossRef Sterne JAC, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, A.J. S J.P.A. I, et al: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 342: d4002-CrossRef
73.
go back to reference McShane LM, Altman DG, Sauerbrei W: Identification of clinically useful cancer prognostic factors: what are we missing?. J Natl Cancer Inst. 2005, 97 (14): 1023-1025. 10.1093/jnci/dji193.CrossRefPubMed McShane LM, Altman DG, Sauerbrei W: Identification of clinically useful cancer prognostic factors: what are we missing?. J Natl Cancer Inst. 2005, 97 (14): 1023-1025. 10.1093/jnci/dji193.CrossRefPubMed
Metadata
Title
Individual participant data meta-analysis of prognostic factor studies: state of the art?
Authors
Ghada Abo-Zaid
Willi Sauerbrei
Richard D Riley
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2012
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-12-56

Other articles of this Issue 1/2012

BMC Medical Research Methodology 1/2012 Go to the issue